肿瘤(癌症)患者之家
首页
癌症知识
肿瘤中医药治疗
肿瘤药膳
肿瘤治疗技术
前沿资讯
登录/注册
VIP特权

文章目录

RNA结合蛋白对MicroRNA的调控及其对癌症的影响

MicroRNA regulation by RNA-binding proteins and its implications for cancer

原文发布日期:2011-08-05

DOI: 10.1038/nrc3107

类型: Review Article

开放获取: 否

要点:

要点翻译:

英文摘要:

摘要翻译: 

原文链接:

文章:

RNA结合蛋白对MicroRNA的调控及其对癌症的影响

MicroRNA regulation by RNA-binding proteins and its implications for cancer

原文发布日期:2011-08-05

DOI: 10.1038/nrc3107

类型: Review Article

开放获取: 否

 

要点:

  1. Global downregulation of microRNA (miRNA) expression is an apparent feature of many tumours. Oncogenic or tumour-suppressive functions have been assigned to numerous miRNAs.
  2. Alterations in key players of miRNA biogenesis affect mature miRNA levels in a global manner, whereas RNA-binding proteins (RBPs) regulating specific miRNAs can contribute to differences in the production of specific (subsets of) miRNAs.
  3. The observation that miRNA binding to target mRNAs can repress gene expression through distinct mechanisms suggests the involvement of accessory proteins, some of which are linked to cancer.
  4. Interplay between miRNAs and RBPs on target 3′ untranslated regions can rapidly modulate target expression under specific conditions. Binding of RBPs near miRNA target sites can potentially regulate miRNA function either directly by affecting miRNA binding or indirectly through a switch in RNA secondary structure.
  5. The activity of RBPs is temporally and spatially regulated through changes in transcription rate, post-translational modifications and subcellular localization, and is sometimes deregulated in cancer and other diseases.
  6. The data discussed in this Review illustrate several examples of mechanisms for miRNA–RBP interplay that could hold true for other miRNAs and RBPs. As some of these mechanisms are linked to oncogenesis, the challenge now is to connect the mechanisms of action to disease by applying state-of-the-art genome-wide approaches.

 

要点翻译:

  1. SWI/SNF染色质重塑复合物的特定亚基失活突变在多种癌症中高频发生,这些亚基包括SNF5(亦称SMARCB1、INI1和BAF47)、ARID1A(亦称BAF250A和SMARCF1)、BAF180(亦称PBRM1)以及BRM/SWI2相关基因1(BRG1;亦称SMARCA4)。
  2. 携带Snf5和Brg1基因突变的基因工程小鼠模型证实,至少部分SWI/SNF亚基具有确切的肿瘤抑制活性。
  3. SWI/SNF复合物通过利用ATP能量重塑染色质来调控基因表达。
  4. 该复合物的核心功能是协调基因表达程序的调控,在细胞谱系分化和维持干细胞多能性过程中发挥关键作用。
  5. 最新证据揭示了SWI/SNF复合物功能紊乱后促进肿瘤发生的关键通路。
  6. 总体而言,修饰染色质结构的酶类正逐渐被视为肿瘤发生的关键调控因子。表观遗传改变具有可逆性潜能(不同于DNA突变),因此靶向抑制染色质修饰酶可能为癌症治疗带来重要突破。

 

英文摘要:

Non-protein-coding transcripts have been conserved throughout evolution, indicating that crucial functions exist for these RNAs. For example, microRNAs (miRNAs) have been found to modulate most cellular processes. The protein classes of RNA-binding proteins include essential regulators of miRNA biogenesis, turnover and activity. RNA–RNA and protein–RNA interactions are essential for post-transcriptional regulation in normal development and may be deregulated in disease. In reviewing emerging concepts of the interplay between miRNAs and RNA-binding proteins, we highlight the implications of these complex layers of regulation in cancer initiation and progression.

摘要翻译: 

非蛋白编码转录本在进化过程中得以保留,表明这些RNA具有重要功能。例如,微RNA(miRNA)被发现能调控大多数细胞过程。RNA结合蛋白的蛋白类别包括miRNA生物生成、周转和活性的关键调控因子。RNA-RNA和蛋白-RNA相互作用对正常发育中的转录后调控至关重要,并可能在疾病中发生失调。在回顾miRNA与RNA结合蛋白相互作用的新兴概念时,我们强调了这些复杂调控层在癌症发生和进展中的意义。

原文链接:

MicroRNA regulation by RNA-binding proteins and its implications for cancer

相关文章

文章:肿瘤抗原优先来源于黑色素瘤和非小细胞肺癌中未突变的基因组序列
文章:年龄相关的烟酰胺腺嘌呤二核苷酸下降驱动CAR-T细胞衰竭
文章:MCSP+转移创始细胞在人类黑色素瘤转移定植早期激活免疫抑制
文章:脂质纳米颗粒递送合成抗原使实体瘤对car介导的细胞毒性敏感
文章:食管癌新辅助治疗中的进化和免疫微环境动力学
文章:CHD1缺失重编程srebp2驱动的胆固醇合成,在spop突变的前列腺肿瘤中促进雄激素响应性生长和去势抵抗
文章:对TIL细胞治疗无反应的转移性非小细胞肺癌患者的T细胞和新抗原保留受损的时间序列分析
文章:策展的癌细胞图谱提供了单细胞分辨率的肿瘤的全面表征
文章:以人群为基础的胶质瘤分子景观分析在青少年和年轻人揭示胶质瘤形成的见解
文章:肿瘤细胞上的PILRα与T细胞表面蛋白CD99相互作用抑制抗肿瘤免疫

……